These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12435252)

  • 21. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses.
    Kjaergard LL; Villumsen J; Gluud C
    Ann Intern Med; 2001 Dec; 135(11):982-9. PubMed ID: 11730399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subverting randomization in controlled trials.
    Schulz KF
    JAMA; 1995 Nov; 274(18):1456-8. PubMed ID: 7474192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials.
    Kunz R; Oxman AD
    BMJ; 1998 Oct; 317(7167):1185-90. PubMed ID: 9794851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Balancing treatment allocations by clinician or center in randomized trials allows unacceptable levels of treatment prediction.
    Hills RK; Gray R; Wheatley K
    J Evid Based Med; 2009 Aug; 2(3):196-204. PubMed ID: 21349013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled trials: allocation concealment, random allocation, and blinding.
    Sedgwick P
    BMJ; 2015 May; 350():h2633. PubMed ID: 25979365
    [No Abstract]   [Full Text] [Related]  

  • 26. Using scratch card technology for random allocation concealment in a clinical trial with a crossover design.
    Beksinska ME; Joanis C; Smit JA; Pienaar J; Piaggio G
    Clin Trials; 2013 Feb; 10(1):125-30. PubMed ID: 23188890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A methodological review of recent meta-analyses has found significant heterogeneity in age between randomized groups.
    Clark L; Fairhurst C; Hewitt CE; Birks Y; Brabyn S; Cockayne S; Rodgers S; Hicks K; Hodgson R; Littlewood E; Torgerson DJ
    J Clin Epidemiol; 2014 Sep; 67(9):1016-24. PubMed ID: 24909873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A theoretical analysis showed that blinding cannot eliminate potential for bias associated with beliefs about allocation in randomized clinical trials.
    Mathieu E; Herbert RD; McGeechan K; Herbert JJ; Barratt AL
    J Clin Epidemiol; 2014 Jun; 67(6):667-71. PubMed ID: 24767518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing allocation concealment and blinding in randomized controlled trials: why bother?
    Schulz KF
    ACP J Club; 2000; 132(2):A11-2. PubMed ID: 10750446
    [No Abstract]   [Full Text] [Related]  

  • 30. The expression of the allocation concealment for randomised controlled trials needs to be improved.
    Zhao X; Yan SG
    Injury; 2011 Apr; 42(4):430-1; author reply 431. PubMed ID: 21145543
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence of improving quality of reporting of randomized controlled trials in subfertility.
    Dias S; McNamee R; Vail A
    Hum Reprod; 2006 Oct; 21(10):2617-27. PubMed ID: 16793995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of allocation concealment and patient blinding in osteoarthritis trials: a meta-epidemiologic study.
    Nüesch E; Reichenbach S; Trelle S; Rutjes AW; Liewald K; Sterchi R; Altman DG; Jüni P
    Arthritis Rheum; 2009 Dec; 61(12):1633-41. PubMed ID: 19950329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study.
    Dechartres A; Trinquart L; Atal I; Moher D; Dickersin K; Boutron I; Perrodeau E; Altman DG; Ravaud P
    BMJ; 2017 Jun; 357():j2490. PubMed ID: 28596181
    [No Abstract]   [Full Text] [Related]  

  • 34. Misuse of randomization: a review of Chinese randomized trials of herbal medicines for chronic hepatitis B.
    Liu J; Kjaergard LL; Gluud C
    Am J Chin Med; 2002; 30(1):173-6. PubMed ID: 12067091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early versus late initiation of renal replacement therapy in patients with acute kidney injury-a systematic review & meta-analysis of randomized controlled trials.
    Bhatt GC; Das RR
    BMC Nephrol; 2017 Feb; 18(1):78. PubMed ID: 28245793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adequacy and reporting of allocation concealment: review of recent trials published in four general medical journals.
    Hewitt C; Hahn S; Torgerson DJ; Watson J; Bland JM
    BMJ; 2005 May; 330(7499):1057-8. PubMed ID: 15760970
    [No Abstract]   [Full Text] [Related]  

  • 37. Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviews.
    Vale CL; Tierney JF; Burdett S
    BMJ; 2013 Apr; 346():f1798. PubMed ID: 23610376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of small randomized controlled trials in surgery may be unreliable.
    Rerkasem K; Rothwell PM
    Br J Surg; 2010 Apr; 97(4):466-9. PubMed ID: 20155790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of selection bias in parallel-group controlled clinical trials in dogs and cats: 97 trials (2000-2005).
    Brown DC
    J Am Vet Med Assoc; 2006 Sep; 229(6):990-3. PubMed ID: 16978121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study.
    Dechartres A; Boutron I; Trinquart L; Charles P; Ravaud P
    Ann Intern Med; 2011 Jul; 155(1):39-51. PubMed ID: 21727292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.